top of page
3WSHT_edited.jpg
Challenges & prospects 2025

6th - 7th December

BROWN ACROPOL_edited_edited_edited.jpg
Healthcare Team Collaboration
Medical Team_edited_edited_edited_edited

  • What is Quality of Care and patient safety?

  • The role of standards and patient safety indicators

  • The Greek national policy

  • The paradigm of Dialysis providers

  • The role of the Renal registries  

  • The UKKA KQI Program

  • The CQC standards and policies for Dialysis Units

  • The importance of staff training, competence and   revalidation

  • Empowering patients to get their voice heard

  • The HASIN accreditation  

Quality of Care & patient safety

SATURDAY 6/12 & SUNDAY 7/12

US procedure.jpg

ΠΡΑΚΤΙΚΗ ΑΣΚΗΣΗ

La-therapie-SeCoHD-Physidia.png
La-therapie-SeCoHD-Physidia_edited_edit

  •   Achieving equity in dialysis care and outcomes: the role       of policies

  •   System-Level Strategies to Improve Home Dialysis​

  •   Patient reported experience and outcome measures

  •   Burden of treatment, social engagement and                       employment across different modalities

  •   Cardiovascular outcomes across different modalities

  •   Τhe role of networks and the interdisciplinary team  

nurses.jpg
nurses_edited.jpg

  •  Haemodialysis protocols

  •  EDTNA accreditation of nursing training

  •  Dry weight assesment

  •  Uremic pruritus: systematic screening,                assessment and novel treatment

  •  IDPN: when, in whom, and how?

​

poster session.jpg

e-Poster session

SUNDAY 7/12

ΕΝΙΝ_Πρόταση_2_edited.jpg
3WSHT_edited_edited.jpg

  • SGLT2 inhibitors: what's new?

  • The place of GLP-1 agonists in clinical practice

  • The MRAs in the treatment of CKD and heart failure

  • Treatment on hyperlipidaemia: what's new?

  • Challenges in the treatment of heart failure

3WSHT_edited_edited.jpg

  • SGLT2 inhibitors: what's new?

  • The place of GLP-1 agonists in clinical practice

  • The MRAs in the treatment of CKD and heart failure

  • Treatment on hyperlipidaemia: what's new?

  • Challenges in the treatment of heart failure

3WSHT_edited_edited.jpg

Κ.10. Clinical dilemmas

  1. HIF inhibitors: what's their place in clinical practice?

  2. What's new in the treatment of hyperphosphataemia?

  3. What's new in the treatment of uraemic pruritus?

  4. How to treat the patient with hyperparathyroidism? 

  5. Dialysate sodium: which to chose?

  6. Dialysate bicarbonate: which to chose?

3WSHT_edited_edited.jpg
3WSHT_edited_edited_edited.jpg

  • Novel & emerging treatments in IgA nephropathy

  • How to treat the patient with IgA nephropathy?

  • Lupus nephritis: what's new

  • Guidelines on hypertension in CKD patients 

  • Clinical trial update on hypertension

debate3_edited_edited_edited_edited.jpg

  • Treatment of hyperphosphatemia

  • Treatment of hyperparathyroidism

  • HIF inhibitors: their place in clinical practice

  • Dialysate sodium

  • Dialysate bicarbonates

bottom of page